Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Magdalou

Showing results (91-100 of 150) with videos related to

Pageof 15
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2004
Stimulation of proteoglycan synthesis by glucuronosyltransferase-I gene delivery: a strategy to promote cartilage repairN Venkatesan, L Barré, A Benani, et al.
Chirality|January 19, 2000
In vitro stereoselective degradation of carprofen glucuronide by human serum albumin. Characterization of sites and reactive amino acidsH Georges, N Presle, T Buronfosse, et al.
Biochemical and Biophysical Research Communications|June 30, 1994
Presence of a retinoid responsive element in the promoter region of the human cytochrome P4501A1 geneF Vecchini, M C Lenoir-Viale, C Cathelineau, et al.
Archives of Biochemistry and Biophysics|March 1, 1994
Chemical modification of human UDP-glucuronosyltransferase UGT1*6 by diethyl pyrocarbonate: possible involvement of a histidine residue in the catalytic processE Battaglia, M Pritchard, M Ouzzine, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 17, 1998
Species-dependent enantioselective glucuronidation of carprofenR Maire-Gauthier, T Buronfosse, J Magdalou, et al.
Molecular Pharmacology|July 1, 1999
Human and rat liver UDP-glucuronosyltransferases are targets of ketoprofen acylglucuronideN Terrier, E Benoit, C Senay, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1994
In vitro N-glucuronidation of SB 47436 (BMS 186295), a new AT1 nonpeptide angiotensin II receptor antagonist, by rat, monkey and human hepatic microsomal fractionsL Perrier, M Bourrié, E Marti, et al.
Therapie|May 1, 1985
[UDP-glucuronosyltransferases and glucuronoconjugation]G Siest, J A Boutin, J Magdalou, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 1, 1997
Photoaffinity labeling studies of the human recombinant UDP-glucuronosyltransferase, UGT1*6, with 5-azido-UDP-glucuronic acidE Battaglia, S Nowell, R R Drake, et al.
Toxicology|November 15, 1996
Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liverM C Canivenc-Lavier, M F Vernevaut, M Totis, et al.
Pageof 15

Showing results (91-100 of 150) with videos related to

Sort By:
Pageof 15
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2004
Stimulation of proteoglycan synthesis by glucuronosyltransferase-I gene delivery: a strategy to promote cartilage repairN Venkatesan, L Barré, A Benani, et al.
Chirality|January 19, 2000
In vitro stereoselective degradation of carprofen glucuronide by human serum albumin. Characterization of sites and reactive amino acidsH Georges, N Presle, T Buronfosse, et al.
Biochemical and Biophysical Research Communications|June 30, 1994
Presence of a retinoid responsive element in the promoter region of the human cytochrome P4501A1 geneF Vecchini, M C Lenoir-Viale, C Cathelineau, et al.
Archives of Biochemistry and Biophysics|March 1, 1994
Chemical modification of human UDP-glucuronosyltransferase UGT1*6 by diethyl pyrocarbonate: possible involvement of a histidine residue in the catalytic processE Battaglia, M Pritchard, M Ouzzine, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 17, 1998
Species-dependent enantioselective glucuronidation of carprofenR Maire-Gauthier, T Buronfosse, J Magdalou, et al.
Molecular Pharmacology|July 1, 1999
Human and rat liver UDP-glucuronosyltransferases are targets of ketoprofen acylglucuronideN Terrier, E Benoit, C Senay, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1994
In vitro N-glucuronidation of SB 47436 (BMS 186295), a new AT1 nonpeptide angiotensin II receptor antagonist, by rat, monkey and human hepatic microsomal fractionsL Perrier, M Bourrié, E Marti, et al.
Therapie|May 1, 1985
[UDP-glucuronosyltransferases and glucuronoconjugation]G Siest, J A Boutin, J Magdalou, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 1, 1997
Photoaffinity labeling studies of the human recombinant UDP-glucuronosyltransferase, UGT1*6, with 5-azido-UDP-glucuronic acidE Battaglia, S Nowell, R R Drake, et al.
Toxicology|November 15, 1996
Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liverM C Canivenc-Lavier, M F Vernevaut, M Totis, et al.
Pageof 15